In June 2023, the National Institute on Aging (NIA) [of the National Institutes of Health(NIH)] released a report on changes in the retina (the layer of cells lining the back wallof the inside the eye that perceives light and signals the brain so one can see) and theirrelationship to stages of Alzheimerās disease (AD). As noted … Continued
by Amanda Bernath During the height of the pandemic, many services, including healthcare, education, shopping, and entertainment, shifted to online platforms. My favorite pandemic changes were the rise of online shopping and the expansion of delivery options and curbside pick-up. The new level of convenience was amazing, especially when it meant I didnāt need to … Continued
Editorās Note: The Foundation Fighting Blindness and the APH ConnectCenter join forces to share about retinal degenerative disease research. Join us for an upcoming webinar! The Foundation Fighting Blindness is the worldās largest private funder of retinal degenerative disease research. For over 50 years, the Foundation has worked diligently to further the mission to drive … Continued
Itās Older Americans Month as well as Healthy Vision Month. This yearās Healthy Vision Month focus is on protecting vision together as a family and finding out about resources for access to eye care. In preparation for Healthy Vision Month, Dr. Sefy Paulose recently updated our eye conditions section, and Dr. Paulose will be presenting … Continued
by Kim Ladd, RN, BS, CPHQ, CDCES Editorās note: Please join us for our upcoming webinar on Resources for Managing Medications with Low or No Vision, January 19, 2022 from 5:00 to 6:30 p.m. eastern. Please register. ACVREP credit will be offered. Effectively Managing Medications If you have a chronic disease, like diabetes, effectively managing … Continued
Recently the APH ConnectCenter Information and Referral Line received questions about the effects of Plaquenil (Hydroxychloroquine sulfate) on your eyes. This is of particular interest during the pandemic as Plaquenil has been discussed as a possible treatment for COVID-19. It was approved by the FDA for a short time as an emergency treatment for the virus at the beginning of the pandemic, until … Continued
Treatments for Dry Macular Degeneration: An Unmet Need Age-Related Macular Degeneration (AMD) is the leading cause of legal blindness in Americans over 65. There are two distinct types of the disease, both of which result in the deterioration of the macula, the central part of the retina that allows a person to see fine detail. … Continued
One of the most significant challenges facing eye and vision researchers is developing an effective treatment for dry age-related macular degeneration (AMD). Although there are now a number of well-regarded FDA-approved drug treatments for wet AMD, the key to effective dry AMD treatment remains elusive, although several potential treatments have emerged in recent years. Current … Continued
New research from Johns Hopkins University School of Medicine reveals that the annual number of new cases of blindness and low vision among people aged 45 years and older is estimated to double during the next 30 years. Because data about the incidence of blindness and low vision in the United States was formally estimated … Continued
by Joy R. Efron, Ed.D. Ā People have asked why I have written three series of articles about my experiences with macular hole and pseudo macular hole. The simple explanation is that I am attempting to reciprocate—to thank the many people who helped me—by helping others. My impressive visual recovery would not have been possible … Continued